TR-1: Standard form for notification of major holdings
| NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i | ||
| | ||
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are at- tached ii: |
Biodexa Pharmaceuticals PLC | |
| 1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X" if appropriate) | ||
| Non-UK issuer | | |
| 2. Reason for the notification(please mark the appropriate box or boxes with an "X") | ||
| An acquisition or disposal of voting rights | x | |
| An acquisition or disposal of financial instruments | | |
| An event changing the breakdown of voting rights | | |
| Other (please specify) iii: | | |
| 3. Details of person subject to the notification obligation iv | ||
| Name | S.H.N Financial Investments | |
| City and country of registered office (if applicable) | Herzliya, Israel | |
| 4. Full name of shareholder(s)(if different from 3.) v | ||
| Name | | |
| City and country of registered office (if applicable) | | |
| 5. Date on which the threshold was crossed or reached vi: |
11th of April 2023 | ||||
| 6. Date on which issuer notified (DD/MM/YYYY): |
11th of April 2023 | ||||
| 7. Total positions of person(s) subject to the notification obligation | |||||
| | % of voting rights at- tached to shares (to- tal of 8. A) | % of voting rights through financial instru- ments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer (8.A + 8.B) vii | |
| Resulting situation on the date on which threshold was crossed or reached |
<3% |
0 |
<3% |
0 | |
| Position of previous notification (if applicable) |
8.37% |
0 |
8.37% |
| |
| 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii | ||||||
| A: Voting rights attached to shares | ||||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |||
| GB00BKT14T00 | 0 | | <3% | | ||
| | | | | | ||
| | | | | | ||
| SUBTOTAL 8. A | 0 | <3% | ||||
| | ||||||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | ||||||
|
Type of financial in- strument |
Expiration date x |
Exercise/ Conversion Period xi | Number of voting rights that may be acquired if the instrument is exercised/converted. |
% of voting rights | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | SUBTOTAL 8. B 1 | | | |||
| B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) | |||||
| Type of financial instrument | Expiration date x | Exercise/ Conversion Pe- riod xi | Physical or cash Settlement xii | Number of voting rights |
% of voting rights |
| | | | | | |
| | | | | | |
| | | | | | |
| | SUBTOTAL 8.B.2 | | | ||
| 9. Information in relation to the person subject to the notification obligation(please mark the applicable box with an "X") | ||||
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii |
x | |||
| Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv | | |||
|
Name xv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial in- struments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | ||||
| 10. In case of proxy voting, please identify: | ||||
| Name of the proxy holder | | |||
| The number and % of voting rights held | | |||
| The date until which the voting rights will be held | | |||
| Place of completion | UK |
| Date of completion | 11.04.2023 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.